Emergent Biosolutions Inc (EBS) earnings · rev $742.9M
These earnings events as JSON? API free 100/dayEmergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
This EBS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported EBS revenue for 2025-12-31 was $742.9M. Net income was $52.6M. Revenue was down 28.8% from 2024-12-31 to 2025-12-31. EBS currently screens at market cap $416.4M.
When the next EBS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 28.8% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full EBS research stays on the stock page; the tape stays on the quote page.
EBS earnings FAQ
What are EBS's latest revenue and net income?
Latest cached Emergent Biosolutions Inc (EBS) revenue for Dec 31, 2025 was $742.9M. Net income was $52.6M. Statements: https://lician.com/financials/ebs
What is EBS's latest diluted EPS?
Latest cached Emergent Biosolutions Inc (EBS) diluted EPS for Dec 31, 2025 was $0.93.
What period does the latest EBS earnings print cover?
The latest cached Emergent Biosolutions Inc (EBS) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did EBS revenue change from the prior cached period?
Cached Emergent Biosolutions Inc (EBS) revenue was down 28.8% from $1.04B (Dec 31, 2024) to $742.9M (Dec 31, 2025). Statements: https://lician.com/financials/ebs
Where are EBS earnings listed?
Cached earnings facts for Emergent Biosolutions Inc (EBS) are listed at https://lician.com/earnings/ebs. Statements: https://lician.com/financials/ebs
Not investment advice.